Delivery Order SPE2DB22D3019-SPE2DB25FK4CR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Yuvafem 10 micrograms vaginal inserts (18 units) under a firm fixed-price contract valued at $1,741.75. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,650.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was made without a set-aside designation...
- The Defense Logistics Agency Medical Supply Chain awarded a $7,508.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Yuvafem 10 microgram vaginal inserts (18-count). This non-set-aside competitive award is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.01 to AmerisourceBergen Drug Corp on August 15, 2025, for Yuvafem 10 micrograms vaginal insert (18 units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction within the federal pharmaceutical supply chain. The contract is set to complete by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YUVAFEM 10 MCG Vaginal Insert (18 count) with a ceiling value of $3,666.12. This firm fixed-price delivery order, awarded on August 8, 2025, represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $15,285.96 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count) on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,602.37 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (8 count) under a firm fixed price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4CRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,161.51 on August 18, 2025, for the supply of Yuvafem 10 mcg Vaginal Insert (18 count). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 19, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System and other government healthcare entities. The company holds extensive delivery order experience through its prime IDC with DLA, fulfilling diverse pharmaceutical and medical supply requirements including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for gynecological pharmaceutical products aligns with AmerisourceBergen's broader role as a comprehensive pharmaceutical prime vendor supporting military and federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/18/25 |